FDA Inspection 1220586 — Ehsan NMI Sadri MD
The FDA completed an inspection of Ehsan NMI Sadri MD on September 15, 2023 in Newport Beach, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 15, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Newport Beach, CA (United States)
Additional Details
Clinical Investigator (CI)